SCHEMBL3406827

SCHEMBL3406827

CC(C)(CN)OC(=O)C1(C(=O)O)CCNCC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.33
KDM4E B2RXH2 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7506165 0.86 KDM4E (0.34) OPRM1KDM4EKMT2A
SCHEMBL2146137 0.81 OPRM1 (0.34) OPRM1KDM4EKMT2A
SCHEMBL9052620 0.76 OPRM1 (0.42) OPRM1KMT2A
SCHEMBL28832911 0.73 OPRM1 (0.40) OPRM1KDM4EKMT2A
SCHEMBL1488529 0.73 OPRM1 (0.54) OPRM1KDM4EKMT2A
SCHEMBL26939775 0.71 ADORA3 (0.33)
SCHEMBL15573619 0.71
SCHEMBL15055670 0.71 KDM4E (0.35) OPRM1KDM4EKMT2A
SCHEMBL825722 0.70 KDM4E (0.38) OPRM1KDM4EKMT2A
SCHEMBL8880684 0.69 RBP4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4362989-A2 A NOVEL KIT FOR RADIOPHARMACEUTICAL PREPARATION OF A RADIOMETAL LABELED CHELATE-FUNCTIONALIZED TARGETING CONJUGATE Life Molecular Imaging Limited (GB) 2024-05-08 EP disclosed
CN-117580595-A Novel kit for radiolabelled chelator functionalized targeted conjugate radiopharmaceutical formulations 生命分子影像有限公司 2024-02-20 CN disclosed
WO-2023275195-A2 A NOVEL KIT FOR RADIOPHARMACEUTICAL PREPARATION OF A RADIOMETAL LABELED CHELATE-FUNCTIONALIZED TARGETING CONJUGATE LIFE MOLECULAR IMAGING LIMITED (GB) 2023-01-05 WO disclosed
WO-2017044899-A1 SYNTHETIC APOLIPOPROTEINS, AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR NANOLIPOPROTEIN PARTICLES FORMATION LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) 2017-03-16 WO disclosed
EP-2252628-A1 BOMBESIN ANALOG PEPTIDE ANTAGONIST CONJUGATES Universitätsspital Basel (CH) 2010-11-24 EP disclosed
WO-2009109332-A1 BOMBESIN ANALOG PEPTIDE ANTAGONIST CONJUGATES UNIVERSITÄTSSPITAL BERN (CH) 2009-09-11 WO disclosed
EP-1320529-A1 QUINOLINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2003-06-25 EP disclosed
EP-1305308-A1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2003-05-02 EP disclosed
EP-1214314-A2 AMINOPIPERIDINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2002-06-19 EP disclosed
WO-2002024684-A1 QUINOLINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM P.L.C. (GB) 2002-03-28 WO disclosed
WO-2002008224-A1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM P.L.C. (GB) 2002-01-31 WO disclosed
WO-2001007432-A2 AMINOPIPERIDINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM P.L.C. (GB) 2001-02-01 WO disclosed